Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
COT
Cotinga Pharmaceuticals Inc. (COT.V)
C$0.04
-41.7%
C$0.03
C$0.02
C$0.12
C$770KN/A20,281 shs1,000 shs
IBT
IBEX Technologies
C$1.44
C$1.43
C$0.75
C$1.45
C$35.29M-0.0868,888 shs200 shs
Valaris Limited stock logo
VAL
Valaris
$67.48
-2.4%
$69.52
$54.13
$78.92
$5.01B1.13704,771 shs519,950 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.00%0.00%0.00%0.00%0.00%
IBT
IBEX Technologies
0.00%0.00%+0.70%+25.22%+66.47%
Valaris Limited stock logo
VAL
Valaris
-2.37%-0.69%-6.32%-1.45%+11.94%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/AN/AN/AN/AN/AN/AN/AN/A
IBT
IBEX Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
3.63 of 5 stars
3.52.00.00.03.01.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/AN/AN/AN/A
IBT
IBEX Technologies
N/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
3.00
Buy$100.0048.19% Upside

Current Analyst Ratings

Latest COT, IBT, BPH, and VAL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/5/2024
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$105.00 ➝ $102.00
2/23/2024
Valaris Limited stock logo
VAL
Valaris
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$107.00 ➝ $105.00
2/14/2024
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$106.00 ➝ $105.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/AN/AC$0.00 per share17.50C($0.18) per shareN/A
IBT
IBEX Technologies
C$8M4.41C$0.92 per share1.56C$0.58 per share2.48
Valaris Limited stock logo
VAL
Valaris
$1.78B2.74$2.47 per share27.37$27.40 per share2.46

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/A-C$0.12N/AN/AN/AN/AN/AN/A
IBT
IBEX Technologies
C$3.98MC$0.159.60N/A49.70%32.13%6.42%6/5/2024 (Estimated)
Valaris Limited stock logo
VAL
Valaris
$865.40M$11.695.776.50N/A48.50%5.71%2.40%5/2/2024 (Confirmed)

Latest COT, IBT, BPH, and VAL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Valaris Limited stock logo
VAL
Valaris
$0.40N/A-$0.40N/AN/AN/A  
2/21/2024Q4 2023
Valaris Limited stock logo
VAL
Valaris
$0.29$0.61+$0.32-$10.08$484.00 million$483.80 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
COT
Cotinga Pharmaceuticals Inc. (COT.V)
C$0.24685.71%N/AN/A N/A
IBT
IBEX Technologies
N/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/A
0.05
0.01
IBT
IBEX Technologies
11.06
6.24
4.93
Valaris Limited stock logo
VAL
Valaris
0.54
1.71
1.71

Ownership

Institutional Ownership

CompanyInstitutional Ownership
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/A
IBT
IBEX Technologies
19.58%
Valaris Limited stock logo
VAL
Valaris
96.74%

Insider Ownership

CompanyInsider Ownership
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/A
IBT
IBEX Technologies
27.03%
Valaris Limited stock logo
VAL
Valaris
0.11%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/A21.99 millionN/ANot Optionable
IBT
IBEX Technologies
N/A24.51 millionN/ANot Optionable
Valaris Limited stock logo
VAL
Valaris
5,98572.41 million72.33 millionOptionable

COT, IBT, BPH, and VAL Headlines

SourceHeadline
Valaris (VAL) Set to Announce Quarterly Earnings on ThursdayValaris (VAL) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - April 25 at 2:32 AM
Louisiana State Employees Retirement System Takes $1.21 Million Position in Valaris Limited (NYSE:VAL)Louisiana State Employees Retirement System Takes $1.21 Million Position in Valaris Limited (NYSE:VAL)
marketbeat.com - April 23 at 4:51 AM
John Fredriksen ally wins seat on board of potential takeover target International SeawaysJohn Fredriksen ally wins seat on board of potential takeover target International Seaways
tradewindsnews.com - April 18 at 10:48 PM
Valaris Limited (NYSE:VAL) Shares Sold by River Road Asset Management LLCValaris Limited (NYSE:VAL) Shares Sold by River Road Asset Management LLC
marketbeat.com - April 18 at 9:34 AM
Interocean announces UT technology demonstrationInterocean announces UT technology demonstration
zawya.com - April 16 at 8:33 AM
Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL)Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL)
marketbeat.com - April 14 at 6:11 AM
Valaris Schedules First Quarter 2024 Earnings Release and Conference CallValaris Schedules First Quarter 2024 Earnings Release and Conference Call
businesswire.com - April 11 at 4:30 PM
Aramco Suspends Valaris Rig ContractAramco Suspends Valaris Rig Contract
rigzone.com - April 11 at 1:38 AM
Valaris (VAL) Receives Rigs Suspension Notice From AramcoValaris (VAL) Receives Rig's Suspension Notice From Aramco
zacks.com - April 9 at 2:26 PM
Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL)Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL)
marketbeat.com - April 9 at 12:12 PM
Port Everglades marks commissioning of new container cranesPort Everglades marks commissioning of new container cranes
en.portnews.ru - April 7 at 11:30 AM
Valaris faces rig suspension in Saudi joint ventureValaris faces rig suspension in Saudi joint venture
investing.com - April 6 at 2:41 AM
Aramco Suspends Another Jack-Up RigAramco Suspends Another Jack-Up Rig
oedigital.com - April 5 at 4:40 PM
Suspension notice for Valaris joint ventureSuspension notice for Valaris joint venture
royalgazette.com - April 5 at 4:40 PM
Saudi Aramco suspends offshore rig deal with New York-listed playerSaudi Aramco suspends offshore rig deal with New York-listed player
upstreamonline.com - April 5 at 1:44 AM
Aramco suspends jackup contract with offshore drillerAramco suspends jackup contract with offshore driller
upstreamonline.com - April 4 at 8:43 PM
Valaris (NYSE:VAL) Shares Gap Down to $76.66Valaris (NYSE:VAL) Shares Gap Down to $76.66
marketbeat.com - April 4 at 2:02 PM
Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc.Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc.
marketbeat.com - April 3 at 4:09 AM
Valaris: Buy Despite Near-Term Jackup Market HeadwindsValaris: Buy Despite Near-Term Jackup Market Headwinds
seekingalpha.com - April 2 at 7:31 PM
VAL Quantitative Stock AnalysisVAL Quantitative Stock Analysis
nasdaq.com - April 1 at 6:26 PM
Valaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from AnalystsValaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from Analysts
marketbeat.com - April 1 at 4:14 AM
Four-way race in heated Petrobras tender for well intervention vesselsFour-way race in heated Petrobras tender for well intervention vessels
upstreamonline.com - March 28 at 4:58 PM
Esgian Week 12 Report: New Finds in Guyana, China and NorwayEsgian Week 12 Report: New Finds in Guyana, China and Norway
marinelink.com - March 24 at 9:59 PM
Activists Across 6 Countries Stage Day of Action Against North Sea Oil DrillingActivists Across 6 Countries Stage Day of Action Against North Sea Oil Drilling
truthout.org - March 17 at 2:06 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cotinga Pharmaceuticals Inc. (COT.V)

CVE:COT
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

IBEX Technologies

CVE:IBT
IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.
Valaris logo

Valaris

NYSE:VAL
Valaris Limited, together with its subsidiaries, provides offshore contract drilling services Gulf of Mexico, South America, North Sea, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Floaters, Jackups, ARO, and Other. It owns an offshore drilling rig fleet, which include drillships, dynamically positioned semisubmersible rigs, moored semisubmersible rig, and jackup rigs. It serves international, government-owned, and independent oil and gas. Valaris Limited was founded in 1975 and is based in Hamilton, Bermuda.